# Allakos

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allakos

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.allakos.com
- Total disclosed funding: $142M
- Latest round: Series B (Nov 30, 2017)
- Investors on record: 11

## About

Established in 2012 and based in California, US, Allakos Inc. is a biotechnology company that develops antibody-based therapeutics to treat inflammatory and various diseases.

## Funding rounds

- Series B, Nov 30, 2017, $100M — Alta Partners, New Enterprise Associates, RiverVest Ventures Partners, Roche Venture Fund, Redmile Group, 503 Partners, Rock Springs Capital, Partner Fund Management, LifeSci Partners, Samsara BioCapital
- Series A, Sep 30, 2014, $10M — Alta Partners, RiverVest Ventures Partners, Novo Holdings, Roche Venture Fund
- Series A, Dec 17, 2012, $32M — Alta Partners, RiverVest Ventures Partners, Novo Holdings, Roche Venture Fund

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A, Series B
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series A, Series B
- Novo Holdings — Series A
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series A, Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series B
- 503 Partners (https://capitalatlas.ai/funds/503-partners) — Series B
- Rock Springs Capital — Series B
- Partner Fund Management — Series B
- LifeSci Partners (https://capitalatlas.ai/funds/lifesci-partners) — Series B
- Samsara BioCapital (https://capitalatlas.ai/funds/samsara-biocapital) — Series B